DejaVoo Introduces New Products: POD Ultra and Ace 2400

Innovation by 2FIRSTS.ai
Aug.30.2024
DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo introduces innovative e-cigarette products, POD Ultra and Ace 2400, blending dual open and closed design on official website.

Recently, two outlets noticed that the e-cigarette brand DejaVoo has launched two new products on its official website: POD Ultra and Ace 2400. According to the website, these two new products combine an open and closed dual design mode.

DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo POD Ultra | Image source: DejaVoo


DejaVoo POD Ultra is a state-of-the-art portable device that allows users to access virtual reality experiences.

DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo POD Ultra User Guide | Image source: DejaVoo


The official website of the DejaVoo brand displays that the DejaVoo POD Ultra utilizes a dual-mode design with both open and closed systems. In addition to a 2ml closed pod, the POD Ultra also features a 2ml open pod inside the device, allowing users to extend their usage time by refilling with e-liquid.

DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo POD Ultra display function|Source: DejaVoo


Specifically, its main features include:

DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo POD Ultra can be replaced with different casings.


Specifications include a puff count of 2400, a nicotine content of 2%, a battery capacity of 1000mAh, and a maximum power output of 10/15W. It utilizes a heating element consisting of either a ceramic core or a mesh core.

DejaVoo Introduces New Products: POD Ultra and Ace 2400
FEELM's products exhibited at the e-cigarette exhibition in Dubai | Image source: 2Firsts.


Additionally, the DejaVoo POD Ultra is equipped with a small display screen that can show real-time information such as e-liquid levels, battery power, output power, and also has a child lock function. Furthermore, this product can be customized with different shells.

DejaVoo Introduces New Products: POD Ultra and Ace 2400
DejaVoo Ace 2400 | Image source: DejaVoo


It is worth noting that the technology used in this product is the same as the solution introduced by Smoore's technology brand FEELM at the e-cigarette exhibition in Dubai in June.


According to the description on the DejaVoo official website, the Ace 2400 model combines open and closed design and uses innovative "4-in-1" technology, allowing users to easily experience four unique flavors by rotating the product. It is worth mentioning that at the bottom of the official product display page, it is clearly stated that this technology comes from FEELM.


DejaVoo Ace's main features include: 2400 puffs, 2% nicotine content, 630mAh battery capacity, maximum 12W power, and a net core heating system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia’s government has withdrawn its appeal against a High Court ruling concerning the regulatory status of liquid nicotine used in vape and e-cigarette products, according to reports by New Straits Times, Free Malaysia Today and CodeBlue on August 18, 2026. The Kuala Lumpur High Court ruled on May 15 that the government’s decision to remove liquid nicotine from the scheduled poisons list under the Poisons Act 1952 was irrational and made without proper consultation with the Poisons Board. The withdrawal ends the government’s appeal process, while the future regulatory framework for nicotine vape products remains under discussion.
Aug.21